SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

August 9, 2005
Date of Report
 (Date of earliest event reported)

RITA Medical Systems, Inc.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation)

000-30959
94-3199149
(Commission File Number)
(I.R.S. Employer Identification No.)

967 N. Shoreline Blvd.
Mountain View, CA 94043
(Address of principal executive offices, with zip code)

(650) 314-3400
(Registrant's telephone number, including area code)

 
 
 

Item 8.01. Other Events and Required FD Disclosure.

On April 9, 2005, RITA Medical Systems, Inc. (Nasdaq: RITA) announced its results of operations for the three and six month periods ended June 30, 2005. A copy of RITA’s press release announcing and commenting upon its results is attached as Exhibit 99.1 hereto and incorporated by reference herein.

 
 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
  RITA Medical Systems, Inc.
 
 		  
 		  
 
Date: August 9, 2005 By:   /s/ Donald Stewart
 
Donald Stewart, Chief Financial Officer and
  Vice President Finance and Administration

 
 
 

RITA MEDICAL SYSTEMS, INC.

INDEX TO EXHIBITS


Exhibit Number
Description
   
99.1
Press Release of RITA Medical Systems, Inc. dated August 9, 2005.